BenzingaSeptember 1, 2026 at 3:10 AM NY3 days ago

Invivyd Continues To Expect Top-Line Data From VYD2311 Program Around The End Of Q3 2026

Invivyd continues to expect top-line data from the VYD2311 program around the end of Q3 2026. At that time, Invivyd plans to either unblind the DECLARATION study in its entirety and submit a Biologics License

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

IVVDInvivyd Inc0.80− 3.65%

Companies in This Story

Related Stories